{"organizations": [], "uuid": "9b4fdb9fa7ff27bd96a6b4b9524f48a8bb871c02", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "https://www.reuters.com/finance/futures", "section_title": "Futures - Markets | Reuters.com", "url": "https://www.reuters.com/article/illumina-patent/update-1-illumina-wins-26-7-mln-in-patent-fight-with-roche-unit-ariosa-idUSL2N1PK1YK", "country": "US", "domain_rank": 408, "title": "UPDATE 1-Illumina wins $26.7 mln in patent fight Roche unit Ariosa", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 1.0, "site_type": "news", "published": "2018-01-26T05:15:00.000+02:00", "replies_count": 0, "uuid": "9b4fdb9fa7ff27bd96a6b4b9524f48a8bb871c02"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/illumina-patent/update-1-illumina-wins-26-7-mln-in-patent-fight-with-roche-unit-ariosa-idUSL2N1PK1YK", "ord_in_thread": 0, "title": "UPDATE 1-Illumina wins $26.7 mln in patent fight Roche unit Ariosa", "locations": [], "entities": {"persons": [{"name": "jan wolfe", "sentiment": "negative"}, {"name": "cynthia osterman", "sentiment": "none"}, {"name": "roche", "sentiment": "none"}, {"name": "ariosa", "sentiment": "none"}, {"name": "richard chang", "sentiment": "none"}], "locations": [{"name": "san francisco", "sentiment": "none"}, {"name": "san diego", "sentiment": "none"}, {"name": "u.s.", "sentiment": "none"}, {"name": "san jose", "sentiment": "none"}], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "roche", "sentiment": "negative"}, {"name": "ariosa diagnostics", "sentiment": "none"}, {"name": "roche holdings ag", "sentiment": "none"}, {"name": "illumina", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "(Adds details of lawsuit, background, byline)\nBy Jan Wolfe\nJan 25 (Reuters) - Gene testing company Illumina on Thursday won a $26.7 million jury verdict in a U.S. lawsuit accusing rival Ariosa Diagnostics, a subsidiary of Roche Holdings AG, of using patented prenatal testing technology without authorization.\nA federal jury in San Francisco said Ariosaâ€™s Harmony non-invasive prenatal test kits infringed on two Illumina patents.\nIllumina and Ariosa compete in the growing market for non-invasive prenatal tests, which screen for chromosomal conditions like Down syndrome.\nSan Diego, California-based Illumina had sought more than $100 million in damages.\nThe jury rejected a counterclaim by Ariosa that Illumina had breached a contract between the companies by bringing the lawsuit. Ariosa had sought $88 million in damages from Illumina on that counterclaim.\nIllumina and Ariosa did not immediately respond to requests for comment.\nRoche acquired San Jose, California-based Ariosa for $625 million in January 2015.\nReporting by Jan Wolfe; Editing by Cynthia Osterman and Richard Chang\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-01-26T05:15:00.000+02:00", "crawled": "2018-01-25T23:20:52.005+02:00", "highlightTitle": ""}